Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80.7M
-
Number of holders
-
129
-
Total 13F shares, excl. options
-
40.1M
-
Shares change
-
-3.75M
-
Total reported value, excl. options
-
$169M
-
Value change
-
-$115M
-
Put/Call ratio
-
0.56
-
Number of buys
-
82
-
Number of sells
-
-59
-
Price
-
$4.22
Significant Holders of Altimmune, Inc. - Common Stock (ALT) as of Q1 2023
192 filings reported holding ALT - Altimmune, Inc. - Common Stock as of Q1 2023.
Altimmune, Inc. - Common Stock (ALT) has 129 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 40.1M shares
of 80.7M outstanding shares and own 49.75% of the company stock.
Largest 10 shareholders include STATE STREET CORP (4.96M shares), Laurion Capital Management LP (3.5M shares), TANG CAPITAL MANAGEMENT LLC (2.75M shares), VANGUARD GROUP INC (2.54M shares), CITADEL ADVISORS LLC (2.04M shares), MARSHALL WACE, LLP (1.6M shares), ARDSLEY ADVISORY PARTNERS LP (1.45M shares), BlackRock Inc. (1.39M shares), Avidity Partners Management LP (1.32M shares), and MILLENNIUM MANAGEMENT LLC (1.07M shares).
This table shows the top 129 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.